On January 21, 2016, KHI’s Tatiana Lin, senior analyst and strategy team leader, presented neutral testimony to the Senate Committee on Corrections and Juvenile Justice for House Bill 2049. This bill, also know as “Otis’s Law,” aims to legalize cannabis oil for seizure-related conditions such as epilepsy. During the testimony, KHI provided a summary of similar “restrictive laws” passed by 17 states as of December 2015. In addition, findings and recommendations were shared with the committee from KHI’s recent completion of a health impact assessment (HIA) on the legalization of medical marijuana in Kansas.
Testimony: A Health Impact Assessment on Legalization of Medical Marijuana in Kansas (HB 2049)
1 Min Read
Jan 22, 2016
ByTatiana Y. Lin, M.A.
About Kansas Health Institute
The Kansas Health Institute supports effective policymaking through nonpartisan research, education and engagement. KHI believes evidence-based information, objective analysis and civil dialogue enable policy leaders to be champions for a healthier Kansas. Established in 1995 with a multiyear grant from the Kansas Health Foundation, KHI is a nonprofit, nonpartisan educational organization based in Topeka.